Carson Wealth (CWM LLC)’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-10
Closed 5293
2025
Q2
$0 Sell
10
-12
-55% -$207 ﹤0.01% 5133
2025
Q1
$0 Buy
22
+15
+214% +$428 ﹤0.01% 5065
2024
Q4
$0 Buy
+7
New +$268 ﹤0.01% 4926
2024
Q3
Sell
-1
Closed 4859
2024
Q2
$0 Hold
1
﹤0.01% 4616
2024
Q1
$0 Buy
+1
New +$84 ﹤0.01% 4345
2023
Q2
Sell
-53
Closed -$2K 4195
2023
Q1
$2K Sell
53
-13
-20% -$679 ﹤0.01% 3623
2022
Q4
$4K Buy
66
+16
+32% +$988 ﹤0.01% 3269
2022
Q3
$5K Buy
50
+39
+355% +$5.55K ﹤0.01% 3044
2022
Q2
$2K Buy
11
+7
+175% +$2.34K ﹤0.01% 3308
2022
Q1
$2K Buy
4
+3
+300% +$1.81K ﹤0.01% 3144
2021
Q4
$1K Buy
+1
New +$764 ﹤0.01% 3260

Other funds holding CDLX

Carson Wealth (CWM LLC)'s CDLX Position: Q3 2025 in Review

Carson Wealth (CWM LLC) sold out of Cardlytics (CDLX) in Q3 2025, closing a stake of 10 shares.

Carson Wealth (CWM LLC) first reported a position in CDLX in Q4 2021 and held it in 11 quarters. The position peaked at $5K in Q3 2022. 81 funds tracked by Wall St. Rank hold CDLX as of Q3 2025.

  • Carson Wealth (CWM LLC) reported no remaining Cardlytics position as of Q3 2025 after selling out during the quarter.
  • Carson Wealth (CWM LLC) sold 10 Cardlytics shares in Q3 2025.
  • Carson Wealth (CWM LLC) first reported a position in Cardlytics in Q4 2021 and held it in 11 quarters.
  • Carson Wealth (CWM LLC)'s Cardlytics position peaked at $5K in Q3 2022.
  • 81 funds tracked by Wall St. Rank held Cardlytics as of Q3 2025.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q3 2025, filed 15 Oct 2025.